BUDD-CHIARI SYNDROME AS THE PRESENTING MANIFESTATION OF ANTIPHOSPHOLIPID SYNDROME

2016 ◽  
Author(s):  
Ângela Sofia Pimenta da Mota
Keyword(s):  
Antiphospholipid Syndrome ◽  
Budd Chiari Syndrome ◽  
Chiari Syndrome

Budd-Chiari syndrome in the context of antiphospholipid syndrome: diagnostic and therapeutic implications

Lupus ◽  
1995 ◽  
Vol 4 (4) ◽  
pp. 329-331 ◽  
Author(s):  
A. Archimandritis ◽  
V. Christopoulou ◽  
M. Tsirantonaki ◽  
P. Vlachoyiannopoulos ◽  
G. Zavos ◽  
...  
Keyword(s):  
Antiphospholipid Syndrome ◽  
Budd Chiari Syndrome ◽  
Therapeutic Implications ◽  
Chiari Syndrome

scholarly journals A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis

2019 ◽  
Vol 12 (5) ◽  
pp. e227450
Author(s):  
Hart A Goldhar ◽  
Paloma O’Meara ◽  
Lana A Castellucci
Keyword(s):  
Antiphospholipid Syndrome ◽  
Lupus Erythematosus ◽  
Vena Cava ◽  
Left Middle Cerebral Artery ◽  
Severe Thrombocytopenia ◽  
Budd Chiari Syndrome ◽  
Reactive Protein ◽  
Chiari Syndrome ◽  
History Of ◽  
New Diagnosis

A 58 year-old left-handed woman was transferred to our hospital with an evolving left middle cerebral artery stroke, severe thrombocytopenia and elevated inflammatory markers. She had a history of chronic Budd-Chiari syndrome (BCS) 16 months prior, attributed to a calcified web in the inferior vena cava that was stented. No thrombophilia testing was performed at that time. The current presentation demonstrated dense right-sided facial and arm paresis and neglect. Erythrocyte sedimentation rate and C-reactive protein were elevated, an autoimmune workup was consistent with a new diagnosis of systemic lupus erythematosus and triple-positive antiphospholipid antibodies. A transesophageal echocardiogram demonstrated a vegetation consistent with Libman-Sacks endocarditis (LSE), thought to have embolised to the brain. The patient was treated acutely with steroids, intravenous immunoglobulin and clopidogrel. This case demonstrates an atypical constellation of the antiphospholipid syndrome, with a novel presentation of BCS and LSE, and reinforces the importance of hypercoagulability screening in this population.

Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome

Medicine ◽  
2001 ◽  
Vol 80 (6) ◽  
pp. 345-354 ◽  
Author(s):  
GERARD ESPINOSA ◽  
JOSEP FONT ◽  
JOAN CARLES GARCÍA-PAGAN ◽  
DOLORS TÀSSIES ◽  
JOAN CARLES REVERTER ◽  
...  
Keyword(s):  
Antiphospholipid Syndrome ◽  
Budd Chiari Syndrome ◽  
Chiari Syndrome

scholarly journals Primary antiphospholipid syndrome presenting as Budd-Chiari syndrome

2016 ◽  
Vol 23 (3) ◽  
pp. 337-338
Author(s):  
Masamichi Komatsu ◽  
Toru Ishihara ◽  
Kosuke Kuwano ◽  
Saki Manabe ◽  
Masayuki Oki ◽  
...  
Keyword(s):  
Antiphospholipid Syndrome ◽  
Primary Antiphospholipid Syndrome ◽  
Budd Chiari Syndrome ◽  
Chiari Syndrome

Budd-Chiari Syndrome Combined With Antiphospholipid Syndrome: Case Report and Literature Review

1993 ◽  
Vol 27 (7) ◽  
pp. 501-509 ◽  
Author(s):  
Shigeomi Shimizu ◽  
Masahiko Miyata ◽  
Wataru Kamiike ◽  
Toshinori Ito ◽  
Makoto Nakamuro ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Antiphospholipid Syndrome ◽  
Budd Chiari Syndrome ◽  
Chiari Syndrome

Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome

1994 ◽  
Vol 21 (1) ◽  
pp. 76-80 ◽  
Author(s):  
Sophie Pelletier ◽  
Bruno Landi ◽  
Jean-Charles Piette ◽  
Philippe Ekert ◽  
Anne Coutellier ◽  
...  
Keyword(s):  
Antiphospholipid Syndrome ◽  
Budd Chiari Syndrome ◽  
Chiari Syndrome
Sign in / Sign up

Export Citation Format

Share Document